• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exelixis, Inc. - Common Stock (NQ:EXEL)

43.58 -0.25 (-0.57%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,489,480
Open 43.52
Bid (Size) 43.58 (600)
Ask (Size) 43.80 (100)
Prev. Close 43.83
Today's Range 43.00 - 43.73
52wk Range 31.90 - 49.62
Shares Outstanding 315,048,788
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
EXELIXIS INC (NASDAQ:EXEL) Combines Strong Fundamentals with Bullish Technical Setup ↗
December 19, 2025
EXELIXIS INC (EXEL) combines strong fundamentals with a bullish technical setup. Its robust earnings growth, zero debt, and accelerating EPS align with a stock poised for a potential breakout. 
Via Chartmill
News headline image
Exelixis Inc (NASDAQ:EXEL) Presents a Compelling Value Investment Case ↗
December 15, 2025
Exelixis (EXEL) is a financially strong oncology biotech with high profitability, zero debt, and a low valuation relative to its earnings growth, fitting key value investing principles. 
Via Chartmill

Performance

YTD
N/A
N/A
1 Month
-1.8%
-1.8%
3 Month
+8.9%
+8.9%
6 Month
-1.3%
-1.3%
1 Year
+28.3%
+28.3%

More News

Read More
News headline image
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
December 12, 2025
From Equity Insider
Via GlobeNewswire
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
News headline image
Preview: Exelixis's Earnings ↗
November 03, 2025
Via Benzinga
News headline image
Exelixis Inc (NASDAQ:EXEL) Emerges as a Prime GARP Candidate with Strong Growth and Sound Valuation ↗
December 12, 2025
Via Chartmill
News headline image
Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth
December 11, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
News headline image
Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025
December 03, 2025
From Exelixis, Inc.
Via Business Wire
News headline image
2 Under-the-Radar Stocks to Buy Heading Into 2026 ↗
December 01, 2025
Via The Motley Fool
News headline image
EXELIXIS INC (NASDAQ:EXEL) Presents a Compelling Value Investment Opportunity ↗
November 21, 2025
Via Chartmill
News headline image
Exelixis Inc (NASDAQ:EXEL) Emerges as a Top Affordable Growth Stock ↗
November 19, 2025
Via Chartmill
News headline image
S&P 500 Surges as Congress Nears End to Protracted Government Shutdown
November 10, 2025
Via MarketMinute
Topics Economy Regulatory Compliance Stocks
News headline image
Global Markets Rally on Hopes for US Government Shutdown Resolution
November 10, 2025
Via MarketMinute
Topics Bonds Economy Government
News headline image
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
November 07, 2025
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in November
November 06, 2025
From Exelixis, Inc.
Via Business Wire
News headline image
Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 04, 2025
From Exelixis, Inc.
Via Business Wire
News headline image
What's Driving the Market Sentiment Around Exelixis Inc? ↗
October 30, 2025
Via Benzinga
News headline image
Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer ↗
October 28, 2025
Via Benzinga
News headline image
EXELIXIS INC (NASDAQ:EXEL) Represents an Affordable Growth Opportunity ↗
October 28, 2025
Via Chartmill
News headline image
Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
October 21, 2025
From Exelixis, Inc.
Via Business Wire
News headline image
This Nextracker Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
October 21, 2025
Via Benzinga
News headline image
Top 3 Health Care Stocks You'll Regret Missing In October ↗
October 21, 2025
Via Benzinga
News headline image
Exelixis Stock Falls After Phase 3 Colorectal Cancer Trial Shows Mixed Results ↗
October 20, 2025
Via Benzinga
News headline image
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
October 20, 2025
Via Benzinga
News headline image
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗
October 20, 2025
Via Benzinga

Frequently Asked Questions

Is Exelixis, Inc. - Common Stock publicly traded?
Yes, Exelixis, Inc. - Common Stock is publicly traded.
What exchange does Exelixis, Inc. - Common Stock trade on?
Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exelixis, Inc. - Common Stock?
The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market
What is the current price of Exelixis, Inc. - Common Stock?
The current price of Exelixis, Inc. - Common Stock is 43.58
When was Exelixis, Inc. - Common Stock last traded?
The last trade of Exelixis, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Exelixis, Inc. - Common Stock?
The market capitalization of Exelixis, Inc. - Common Stock is 13.73B
How many shares of Exelixis, Inc. - Common Stock are outstanding?
Exelixis, Inc. - Common Stock has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap